·07/05/08 Hodgkin disease to Hodgkin lymphoma: biologic insights and therapeutic potential
·07/05/08 Copper-dependent activation of hypoxia-inducible factor (HIF)-1: implications for ceruloplasmin regulation
·07/05/08 An RNA interference model of RPS19 deficiency in Diamond-Blackfan anemia recapitulates defective hematopoiesis and rescue by dexamethasone: identification of dexamethasone-responsive genes by microarr
·07/05/08 Deficiency of ribosomal protein S19 in CD34+ cells generated by siRNA blocks erythroid development and mimics defects seen in Diamond-Blackfan anemia
·07/05/08 Angiopoietin-1 promotes lymphatic sprouting and hyperplasia
·07/05/08 Angiopoietin-1 promotes LYVe-1-positive lymphatic vessel formation
·07/05/08 High level of endothelial cell-specific gene expression by a combination of the 5' flanking region and the 5' half of the first intron of the Ve-cadherin gene
·07/05/08 A classification system for cross-reactive material-negative factor XI deficiency
·07/05/08 Intracellular interaction of von Willebrand factor and factor VIII depends on cellular context: lessons from platelet-expressed factor VIII
·07/05/08 Human cytotoxic T lymphocytes with reduced sensitivity to Fas-induced apoptosis
·07/05/08 Identification of carboxypeptidase N as an enzyme responsible for C-terminal cleavage of stromal cell-derived factor-1 in the circulation
·07/05/08 Src homology 2 domain-containing inositol-5-phosphatase 1 (SHIP1) negatively regulates TLR4-mediated LPS response primarily through a phosphatase activity- and PI-3K-independent mechanism
·07/05/08 HIV-1 incorporates ABO histo-blood group antigens that sensitize virions to complement-mediated inactivation
·07/05/08 A functional analysis of the putative polymorphisms A91V and N252S and 22 missense perforin mutations associated with familial hemophagocytic lymphohistiocytosis
·07/05/08 Activation of Th1 and Tc1 cell adenosine A2A receptors directly inhibits IL-2 secretion in vitro and IL-2-driven expansion in vivo
·07/05/08 Ontogeny of CD4+CD25+ regulatory/suppressor T cells in human fetuses
·07/05/08 Molecular basis for positive and negative signaling by the natural killer cell receptor 2B4 (CD244)
·07/05/08 Impaired base excision repair and accumulation of oxidative base lesions in CD4+ T cells of HIV-infected patients
·07/05/08 expression of SphK1 impairs degranulation and motility of RBL-2H3 mast cells by desensitizing S1P receptors
·07/05/08 Rapamycin selectively expands CD4+CD25+FoxP3+ regulatory T cells
·07/05/08 Human TSLP promotes CD40 ligand-induced IL-12 production by myeloid dendritic cells but maintains their Th2 priming potential
·07/05/08 Gaucher disease and cancer incidence: a study from the Gaucher Registry
·07/05/08 Pharmacogenetics of outcome in children with acute lymphoblastic leukemia
·07/05/08 Farnesyltransferase inhibitor R115777 (Zarnestra, Tipifarnib) synergizes with paclitaxel to induce apoptosis and mitotic arrest and to inhibit tumor growth of multiple myeloma cells
·07/05/08 Stress-induced activation of the p53 tumor suppressor in leukemia cells and normal lymphocytes requires mitochondrial activity and reactive oxygen species
·07/05/08 Human chronic lymphocytic leukemia B cells can escape DNA damage-induced apoptosis through the nonhomologous end-joining DNA repair pathway
·07/05/08 Role of selectins in the triggering, growth, and dissemination of T-lymphoma cells: implication of L-selectin in the growth of thymic lymphoma
·07/05/08 Telomere length as a prognostic parameter in chronic lymphocytic leukemia with special reference to VH gene mutation status
·07/05/08 CLL, but not normal, B cells are dependent on autocrine VeGF and 41 integrin for chemokine-induced motility on and through endothelium
·07/05/08 Sustained signaling through the B-cell receptor induces Mcl-1 and promotes survival of chronic lymphocytic leukemia B cells
·07/05/08 Fibromodulin, an extracellular matrix protein: characterization of its unique gene and protein expression in B-cell chronic lymphocytic leukemia and mantle cell lymphoma
·07/05/08 Myelodysplasia and acute myeloid leukemia following therapy for indolent lymphoma with fludarabine, mitoxantrone, and dexamethasone (FND) plus rituximab and interferon alpha
·07/05/08 Intronic splicing of hyaluronan synthase 1 (HAS1): a biologically relevant indicator of poor outcome in multiple myeloma
·07/05/08 Phenotypic characterization of the human myeloma cell growth fraction
·07/05/08 Fusion of eML1 to ABL1 in T-cell acute lymphoblastic leukemia with cryptic t(9;14)(q34;q32)

1 [2] [下一页] [尾页]